1. Home
  2. TRI vs KVUE Comparison

TRI vs KVUE Comparison

Compare TRI & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thomson Reuters Corp

TRI

Thomson Reuters Corp

HOLD

Current Price

$105.56

Market Cap

37.0B

Sector

N/A

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$18.12

Market Cap

36.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRI
KVUE
Founded
1851
2022
Country
Canada
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
37.0B
36.6B
IPO Year
2002
2023

Fundamental Metrics

Financial Performance
Metric
TRI
KVUE
Price
$105.56
$18.12
Analyst Decision
Buy
Buy
Analyst Count
11
11
Target Price
$164.55
$19.64
AVG Volume (30 Days)
3.8M
48.2M
Earning Date
01-01-0001
05-19-2026
Dividend Yield
2.45%
4.39%
EPS Growth
N/A
40.74
EPS
N/A
0.76
Revenue
N/A
$15,124,000,000.00
Revenue This Year
$8.86
$4.07
Revenue Next Year
$7.86
$2.92
P/E Ratio
$25.72
$24.89
Revenue Growth
N/A
N/A
52 Week Low
$79.71
$14.02
52 Week High
$218.40
$25.17

Technical Indicators

Market Signals
Indicator
TRI
KVUE
Relative Strength Index (RSI) 57.23 46.34
Support Level $79.71 $16.73
Resistance Level $135.03 $18.97
Average True Range (ATR) 5.16 0.39
MACD 3.36 -0.06
Stochastic Oscillator 99.46 12.70

Price Performance

Historical Comparison
TRI
KVUE

About TRI Thomson Reuters Corp

Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: